Shuichi Hanada Selected Research

Quinidine (Chinidin)

4/2002

Augmentation of the activity of an immunotoxin, anti-Tac(Fv)-PE40KDEL, in T cell lines infected with human T cell leukemia virus type-I.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuichi Hanada Research Topics

Disease

8	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2015 - 02/2002
3	Lymphoma (Lymphomas) 01/2018 - 02/2002
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2017 - 12/2008
2	Hypersensitivity (Allergy) 06/2023 - 01/2019
2	Neoplasms (Cancer) 12/2015 - 03/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 01/2007
2	Neutropenia 12/2007 - 02/2002
2	Thrombocytopenia (Thrombopenia) 12/2007 - 02/2002
2	T-Cell Leukemia (Leukemia, T Cell) 05/2002 - 04/2002
1	Hepatocellular Carcinoma (Hepatoma) 06/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Wilms Tumor (Wilm's Tumor) 01/2019
1	Lymphadenopathy 01/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2013
1	Anemia 10/2012
1	Multiple Myeloma 10/2012
1	Renal Insufficiency (Renal Failure) 10/2012
1	Pulmonary Embolism 01/2012
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2010
1	Infections 12/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2007
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2007
1	Leukemia 05/2003
1	Acute Promyelocytic Leukemia 05/2002
1	Body Weight (Weight, Body) 02/2002

Drug/Important Bio-Agent (IBA)

3	Rituximab (Mabthera)FDA Link 12/2017 - 12/2008
2	Thrombopoietin (c-mpl Ligand)IBA 06/2023 - 02/2002
2	mogamulizumabIBA 01/2018 - 03/2010
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2007 - 02/2002
1	VaccinesIBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017
1	Podophyllotoxin (Condylox)FDA LinkGeneric 01/2015
1	AnthracyclinesIBA 01/2015
1	Alkylating AgentsIBA 01/2015
1	HepcidinsIBA 10/2012
1	CreatinineIBA 10/2012
1	IronIBA 10/2012
1	AnticoagulantsIBA 01/2012
1	AntigensIBA 03/2009
1	ranimustineIBA 12/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2007
1	Vincristine (Oncovin)FDA LinkGeneric 12/2007
1	Vindesine (Vindesin)IBA 12/2007
1	Adenosine Monophosphate (AMP)IBA 12/2007
1	Carboplatin (JM8)FDA LinkGeneric 12/2007
1	Prednisone (Sone)FDA LinkGeneric 12/2007
1	Etoposide (VP 16)FDA LinkGeneric 12/2007
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2007
1	Cladribine FDA LinkGeneric 08/2007
1	Interleukin-7 (Interleukin 7)IBA 05/2003
1	Arsenic Trioxide (Trisenox)FDA Link 05/2002
1	CaspasesIBA 05/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2002
1	PAK 200IBA 04/2002
1	Monoclonal AntibodiesIBA 04/2002
1	B3(Fv)-PE38KDEL recombinant immunotoxinIBA 04/2002
1	Immunotoxins (Immunotoxin)IBA 04/2002
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2002
1	Proteins (Proteins, Gene)FDA Link 04/2002
1	ExotoxinsIBA 04/2002
1	cepharanthineIBA 04/2002
1	Quinidine (Chinidin)FDA LinkGeneric 04/2002

Therapy/Procedure

6	Therapeutics 01/2019 - 02/2002
5	Drug Therapy (Chemotherapy) 01/2019 - 02/2002
2	Combination Drug Therapy (Combination Chemotherapy) 12/2015 - 01/2015
1	Hepatectomy 06/2020
1	Blood Transfusion (Blood Transfusions) 06/2020
1	Hematopoietic Stem Cell Transplantation 12/2015
1	Remission Induction 12/2008
1	Stem Cell Transplantation 09/2007